Telix Pharmaceuticals Ltd
ASX:TLX
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
AU |
|
News Corp
F:NC0E
|
US |
Intrinsic Value
The intrinsic value for
Telix Pharmaceuticals Ltd (TLX) under the Base Case is 11.97 AUD.
Compared with the current market price of 14.72 AUD, the stock appears
Overvalued by 19% .
DCF suggests overvaluation, while multiples suggest undervaluation.
Let our AI compare Alpha Spread’s intrinsic value with external valuations from Simply Wall St, GuruFocus, ValueInvesting.io, Seeking Alpha, and others.
Let our AI break down the key assumptions behind the intrinsic value calculation for Telix Pharmaceuticals Ltd.
The intrinsic value for
Telix Pharmaceuticals Ltd (TLX) under the Base Case is 11.97 AUD.
Compared with the current market price of 14.72 AUD, the stock appears Overvalued by 19% .